ITGA11 and ovarian cancer: We found high expression of ITGA11 was correlated with poor prognosis in breast cancer patients, which is in agreement with previous studies that Integrin expression levels are correlated with prognosis in glioblastoma, melanoma, gastric cancer, cervical cancer, and ovarian cancer [30–33].